Trade Mark Journal No.2026/021 22 May 2026

WO0000001916066 (9,42,44)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:2 March 2026
Date of designation in the UK: 2 March 2026
Image for mark 1916066_TIF TDBASE

International priority date claimed: 20 October 2025 (European Union Intellectual Property Office (EUIPO)) (019263400)
Class 9
Electronic databases; recorded data files; computer software applications, downloadable; computer software relating to the medical field; computer software for database management; data sets, recorded or downloadable; database server software; web application software; interactive database software; computer programs for accessing, browsing and searching online databases; software as a medical device [SaMD], downloadable; the aforesaid goods relating to the medical, pharmaceutical and therapeutic field and none of the aforesaid goods relating to banking, finance, investment or insurance services.
Class 42
Design and development of electronic database software; services for assessing the efficiency of pharmaceuticals; services for assessing the efficiency of veterinary drugs; pharmaceutical product evaluation; testing of pharmaceuticals; providing temporary use of on-line non-downloadable software for database management; pharmaceutical research services; biomedical research services; none of the aforesaid services relating to banking, finance, investment or insurance services.
Class 44
Veterinary advisory services; dietary and nutritional advice; health care relating to homeopathy; health care relating to naturopathy; herbalism; pharmaceutical services; providing information relating to dietary and nutritional supplements; providing information to patients in the field of administering medications; provision of pharmaceutical information; providing information relating to the preparation and dispensing of medications; pharmacy advice services; advisory services relating to pharmaceuticals; consultancy and information services relating to biopharmaceutical products; consultancy and information services relating to pharmaceutical products; toxicology testing for medical purposes.

Medbase Group Oy

Representative: BERGGREN OY, Fabianinkatu 21, FI-00130 Helsinki, FINLAND